- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05538416
Short-term Clinical Outcome of Cortical Bone Trajectory Compared With the Traditional "Open" and Minimal Invasive Posterior Lumbar Interbody Fusion
Study Overview
Status
Intervention / Treatment
Detailed Description
A combined prospective cohort study for CBT-PLIF and retrospective analysis of prospectively collected data from the MISOS study, regarding traditional open PLIF and MI-PLIF. A total of 180 patients will be included in the study: 60 prospective CBT-PLIF patients, 60 retrospective open PLIF patients and 60 retrospective MI-PLIF patients.
The new data will be collected prospectively by means of questionnaires. No biomaterial will be collected. The included patients will be asked to complete questionnaires before surgery, 2 and 6 weeks after surgery. In addition, VAS scores will be noted throughout the hospital stay, 2 and 6 weeks after surgery.
Inclusion criteria: Patients aged 18-75 years with neurogenic claudication and/or radicular leg pain due to low-grade (Meyerding grades l and ll) degenerative or spondylolytic spondylolisthesis with persistent symptoms for more than 3 months.
Exclusion criteria: previous spinal fusion surgery at the same level, osteoporosis (only when using bisphosphonate), active infection or previous infection at the surgical site, active cancer, spondylolisthesis grade III or greater, more than one symptomatic level requiring fusion, pregnancy, contraindication to surgery, severe mental or psychiatric disorder, substance abuse, insufficient knowledge of the Dutch language and morbid obesity (body mass index >40).
Main research question: Does the CBT-PLIF provide less low back pain in the short term than the traditional open PLIF and the MI-PLIF?
Primary outcome measure
- Low back pain measured with the Visual Analogue Scale (VAS) 2 weeks after surgery Secondary Outcomes
- Low back pain during hospitalization (measured every day), 2 and 6 weeks after surgery
- Leg pain
- Oswestry Disability Index
- Quality of life (EQ-5D-5L)
- Observed patient recovery
- Other parameters such as complications, surgical parameters (intraoperative blood loss, duration of surgery), length of stay in hospital and return to work
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Diane H. Steenks
- Phone Number: 050 3617976
- Email: d.h.steenks@umcg.nl
Study Contact Backup
- Name: Hui Ling Li, BsC
- Phone Number: 0629249620
- Email: h.l.li@umcg.nl
Study Locations
-
-
-
Groningen, Netherlands, 9713 GZ
- Recruiting
- UMCG
-
Contact:
- Jos MA Kuijlen, MD/PHD
- Phone Number: 050 361 2837
- Email: jmakuijlen@umcg.nl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18-75 years
- Degenerative or spondylolytic spondylolisthesis
- Neurogenic claudication and/or radicular leg pain
- Low grade (Meyerding grade l and ll)
- Persistent complaints for over 3 months
Exclusion Criteria:
- Previous spine fusion surgery at the same level
- Osteoporosis
- Active infection or prior infection at the surgical site
- Active cancer
- Spondylolisthesis grade lll or greater
- More than one symptomatic level that needs fusion
- Pregnancy
- Contraindication for surgery
- Severe mental or psychiatric disorder
- Substance abuse
- Inadequate knowledge of Dutch language
- Morbid obesity (body mass index >40)
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Open PLIF
Patients undergoing conventional open posterior lumbar interbody fusion (PLIF) surgery.
A long midline skin incision (10-15 cm) is made, after which the paravertebral muscles are detached from the midline and retracted laterally in order to expose the facet joints and pedicle entry point.
After the pedicle screws are positioned, the disc will be removed bilaterally and packed with autogenous bone chips, followed by bilateral placement of polyetheretherketone (PEEK) PLIF cages.
|
Spinal fusion in the lumbar spine by inserting a cage directly into the disc space.
This is an observational study in which the standard procedure/care is followed.
|
|
CBT-PLIF
Patient undergoing minimal access PLIF surgery with cortical bone trajectory (CBT-PLIF).
The CBT-PLIF uses more medialized entry points, closer to the spinal process.
Due to the medial approach of this technique, a smaller incision is needed and the need to retract muscles laterally is minimalized.
|
Spinal fusion in the lumbar spine by inserting a cage directly into the disc space.
This is an observational study in which the standard procedure/care is followed.
|
|
MI-PLIF
Patients undergoing minimal invasive PLIF surgery.
A small midline incision (3-5 cm) will be made to perform mini-open decompression and placement of bilateral PEEK PLIF cages.
In addition, two small paramedian incisions will be made on both sides for percutaneous pedicle screw fixation.
|
Spinal fusion in the lumbar spine by inserting a cage directly into the disc space.
This is an observational study in which the standard procedure/care is followed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VAS low back pain
Time Frame: 2 weeks postoperative
|
VAS for low back pain ranging from 0mm (no pain) to 100mm (worst pain imaginable)
|
2 weeks postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VAS low back pain
Time Frame: During hospital stay, measured each day and 6 weeks postoperative
|
VAS for low back pain ranging from 0mm (no pain) to 100mm (worst pain imaginable)
|
During hospital stay, measured each day and 6 weeks postoperative
|
|
VAS leg pain
Time Frame: During hospital stay, measured each day, 2 and 6 weeks postoperative
|
VAS for leg pain ranging from 0mm (no pain) to 100mm (worst pain imaginable)
|
During hospital stay, measured each day, 2 and 6 weeks postoperative
|
|
Oswestry Disability Index
Time Frame: 2 and 6 weeks postoperative
|
Used to quantify the degree of functional impairment in patients with low back pain.
Ranging from 0 (no disability) to 100 (bed bound)
|
2 and 6 weeks postoperative
|
|
Quality of Life (QoL)
Time Frame: 2 and 6 weeks postoperative
|
Measured by the EQ-5D-5L
|
2 and 6 weeks postoperative
|
|
Perceived recovery of the patient
Time Frame: 2 and 6 weeks postoperative
|
scored on a 7-Likert scale, with scores ranging from 'worse than ever' to 'complete recovery'
|
2 and 6 weeks postoperative
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jos M.A. Kuijlen, MD, PhD, University Medical Centre Groningen (UMCG), Hanzeplein 1, 9713GZ Groningen
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UMCG202200129
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Spondylolisthesis
-
NuVasiveCompletedDegenerative Disc Disease | Degenerative Scoliosis | Degenerative SpondylolisthesisUnited States
-
The Fourth Affiliated Hospital of Zhejiang University...Recruiting
-
NuVasiveCompletedDegenerative Disc Disease | Degenerative Scoliosis | Degenerative SpondylolisthesisUnited States
-
Zimmer BiometCompletedDegenerative Disc Disease | Degenerative SpondylolisthesisUnited States
-
Seton Healthcare FamilyCelling BiosciencesWithdrawnDegenerative Disc Disease | Spinal Stenosis | Degenerative Spondylolisthesis | Isthmic-lytic SpondylolisthesisUnited States
-
Lahey ClinicDePuy SynthesCompletedLumbar Spondylolisthesis | Lumbar Spondylosis | Degenerative SpondylolisthesisUnited States
-
Mesoblast, Ltd.CompletedSpinal Stenosis | Cervical Degenerative Disc Disease | Degenerative SpondylolisthesisUnited States
-
National Taiwan University HospitalCompletedDegenerative Disc Disease | Degenerative Spondylolisthesis | Degenerative Intervertebral Discs | Degenerative Lumbar Spinal StenosisTaiwan
-
University of Maryland, BaltimoreWithdrawnDegenerative Disc Disease | Degenerative Spondylolisthesis | Degenerative Lumbar Spinal Stenosis | Degenerative DiseaseUnited States
-
Haukeland University HospitalActive, not recruitingDegenerative Lumbar SpondylolisthesisNorway
Clinical Trials on Posterior Lumbar Interbody Fusion (PLIF)
-
ExactechTerminatedDegenerative Disc Disease | Spondylolisthesis | StenosisUnited States
-
NuVasiveCompletedLumbar Degenerative Disc DiseaseUnited States
-
Assiut UniversityCompletedLumbar Spine FusionEgypt
-
Spine and Scoliosis Research AssociatesCompletedDegenerative Disc Disease (DDD)United States
-
The London Spine CentreUnknownDegenerative Lumbar SpondylolisthesisCanada
-
AOSpine North America Research NetworkCompletedIsthmic SpondylolisthesisUnited States, Canada
-
The London Spine CentreUnknownSpinal Stenosis | Degenerative SpondylolisthesisCanada
-
Assiut UniversityUnknown
-
Silony Medical GmbHActive, not recruitingDegenerative Cervical Disc Disease | Degenerative Lumbar DiseasesUnited States
-
Premia SpineCompletedLumbar Spinal Stenosis | Degenerative SpondylolisthesisUnited States